Literature DB >> 26631045

MicroRNA-613 inhibited ovarian cancer cell proliferation and invasion by regulating KRAS.

Xin Fu1, Yanfen Cui2, Shaobin Yang2, Yue Xu2, Zicheng Zhang3.   

Abstract

MicroRNAs (miRNAs) play several important roles in carcinogenesis, and the dysregulation of miRNAs is associated with cancer progression. Little is known about the role of miR-613 in ovarian cancer. In the present study, we demonstrate that miR-613 expression is downregulated in human ovarian cancer cell lines and tissues. Additionally, miR-613 overexpression suppressed ovarian cancer cell proliferation, colony formation, and invasion. Furthermore, KRAS was identified as a target of miR-613. Reintroducing KRAS rescued the inhibitory effects exerted by miR-613 on ovarian cancer cell proliferation and invasion. Taken together, our findings suggest that miR-613 functions as a candidate tumor suppressor miRNA in ovarian cancer by directly targeting KRAS. To the best of our knowledge, this is the first study to show that miR-613 affects the proliferation and invasion of ovarian cancer.

Entities:  

Keywords:  KRAS; MicroRNAs; Ovarian cancer; miR-613

Mesh:

Substances:

Year:  2015        PMID: 26631045     DOI: 10.1007/s13277-015-4507-7

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  39 in total

1.  MiR-138 induces renal carcinoma cell senescence by targeting EZH2 and is downregulated in human clear cell renal cell carcinoma.

Authors:  Jiaqian Liang; Yajing Zhang; Guosong Jiang; Zhouqiang Liu; Wei Xiang; Xuanyu Chen; Zhaohui Chen; Jun Zhao
Journal:  Oncol Res       Date:  2013       Impact factor: 5.574

2.  miR-613 regulates cholesterol efflux by targeting LXRα and ABCA1 in PPARγ activated THP-1 macrophages.

Authors:  Ranzun Zhao; Jian Feng; Guoxiang He
Journal:  Biochem Biophys Res Commun       Date:  2014-04-18       Impact factor: 3.575

3.  Analysis of hsa-miR-30a-5p expression in human gliomas.

Authors:  Kun Wang; Zhifan Jia; Jian Zou; Anling Zhang; Guangxiu Wang; Jianwei Hao; Yirong Wang; Shuxu Yang; Peiyu Pu
Journal:  Pathol Oncol Res       Date:  2013-04-20       Impact factor: 3.201

4.  The identification of miR-375 as a potential biomarker in distal gastric adenocarcinoma.

Authors:  Wen-Hui Zhang; Jun-Hao Gui; Chang-Zheng Wang; Qing Chang; Shi-Ping Xu; Chang-Hao Cai; Ying-Nan Li; Ya-Ping Tian; Li Yan; Benyan Wu
Journal:  Oncol Res       Date:  2012       Impact factor: 5.574

5.  MicroRNA hsa-miR-613 targets the human LXRα gene and mediates a feedback loop of LXRα autoregulation.

Authors:  Zhimin Ou; Taira Wada; Roberto Gramignoli; Song Li; Stephen C Strom; Min Huang; Wen Xie
Journal:  Mol Endocrinol       Date:  2011-02-10

6.  Tumor suppressive microRNA-1285 regulates novel molecular targets: aberrant expression and functional significance in renal cell carcinoma.

Authors:  Hiedo Hidaka; Naohiko Seki; Hirofumi Yoshino; Takeshi Yamasaki; Yasutoshi Yamada; Nijiro Nohata; Miki Fuse; Masayuki Nakagawa; Hideki Enokida
Journal:  Oncotarget       Date:  2012-01

Review 7.  MicroRNA dysregulation in uveal melanoma: a new player enters the game.

Authors:  Zheng Li; Xin Yu; Jianxiong Shen; Yang Jiang
Journal:  Oncotarget       Date:  2015-03-10

8.  Clinicopathological correlates and prognostic significance of KRAS mutation status in a pooled prospective cohort of epithelial ovarian cancer.

Authors:  Björn Nodin; Nooreldin Zendehrokh; Magnus Sundström; Karin Jirström
Journal:  Diagn Pathol       Date:  2013-06-25       Impact factor: 2.644

9.  MiR-101 suppresses the epithelial-to-mesenchymal transition by targeting ZEB1 and ZEB2 in ovarian carcinoma.

Authors:  Fei Guo; David Cogdell; Limei Hu; Da Yang; Anil K Sood; Fengxia Xue; Wei Zhang
Journal:  Oncol Rep       Date:  2014-03-21       Impact factor: 3.906

10.  Extensive sequence variation in the 3' untranslated region of the KRAS gene in lung and ovarian cancer cases.

Authors:  Minlee Kim; Xiaowei Chen; Lena J Chin; Trupti Paranjape; William C Speed; Kenneth K Kidd; Hongyu Zhao; Joanne B Weidhaas; Frank J Slack
Journal:  Cell Cycle       Date:  2014-02-03       Impact factor: 5.173

View more
  11 in total

1.  miR-613 inhibits gastric cancer progression through repressing brain derived neurotrophic factor.

Authors:  Dayong Ding; Ruizhi Hou; Yongjian Gao; Ye Feng
Journal:  Exp Ther Med       Date:  2017-11-23       Impact factor: 2.447

2.  miR-613 inhibits bladder cancer proliferation and migration through targeting SphK1.

Authors:  Haifeng Yu; Ping Duan; Haibo Zhu; Dapang Rao
Journal:  Am J Transl Res       Date:  2017-03-15       Impact factor: 4.060

Review 3.  A comprehensive survey into the role of microRNAs in ovarian cancer chemoresistance; an updated overview.

Authors:  Ahmad Saburi; Mohammad Saeed Kahrizi; Navid Naghsh; Hasti Etemadi; Ahmet İlhan; Ali Adili; Shadi Ghoreishizadeh; Rozita Tamjidifar; Morteza Akbari; Gülinnaz Ercan
Journal:  J Ovarian Res       Date:  2022-07-07       Impact factor: 5.506

4.  LncRNA EWSAT1 promotes ovarian cancer progression through targeting miR-330-5p expression.

Authors:  Xin Fu; Li Zhang; Li Dan; Ke Wang; Yue Xu
Journal:  Am J Transl Res       Date:  2017-09-15       Impact factor: 4.060

5.  Identification of immune-enhanced molecular subtype associated with BRCA1 mutations, immune checkpoints and clinical outcome in ovarian carcinoma.

Authors:  Mingjun Zheng; Yuexin Hu; Rui Gou; Ouxuan Liu; Xin Nie; Xiao Li; Qing Liu; Yingying Hao; Juanjuan Liu; Bei Lin
Journal:  J Cell Mol Med       Date:  2020-01-29       Impact factor: 5.310

6.  Clinical Potentials of miR-576-3p, miR-613, NDRG2 and YKL40 in Colorectal Cancer Patients.

Authors:  Manal Nasreddin Eldaly; Fateheya Mohamed Metwally; Wafaa Ghoneim Shousha; Abeer Salah El-Saiid; Shimaa Shawki Ramadan
Journal:  Asian Pac J Cancer Prev       Date:  2020-06-01

7.  MicroRNA-613 inhibits cell growth, migration and invasion of papillary thyroid carcinoma by regulating SphK2.

Authors:  Wangwang Qiu; Zhili Yang; Youben Fan; Qi Zheng
Journal:  Oncotarget       Date:  2016-06-28

8.  Tumor suppressor microRNA‑613 inhibits glioma cell proliferation, invasion and angiogenesis by targeting vascular endothelial growth factor A.

Authors:  Xiongwu Yu; Weimin Wang
Journal:  Mol Med Rep       Date:  2017-09-05       Impact factor: 2.952

Review 9.  Small Non-Coding-RNA in Gynecological Malignancies.

Authors:  Shailendra Kumar Dhar Dwivedi; Geeta Rao; Anindya Dey; Priyabrata Mukherjee; Jonathan D Wren; Resham Bhattacharya
Journal:  Cancers (Basel)       Date:  2021-03-03       Impact factor: 6.575

10.  Long noncoding RNA FAM225B facilitates proliferation and metastasis of nasopharyngeal carcinoma cells by regulating miR-613/CCND2 axis.

Authors:  Weijun Dai; Yi Shi; Weiqi Hu; Chenjie Xu
Journal:  Bosn J Basic Med Sci       Date:  2022-02-01       Impact factor: 3.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.